JERICHO SCIENCES Trademark

Trademark Overview


On Saturday, February 3, 2018, a trademark application was filed for JERICHO SCIENCES with the United States Patent and Trademark Office. The USPTO has given the JERICHO SCIENCES trademark a serial number of 87783010. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 27, 2021. This trademark is owned by Jericho Sciences, LLC. The JERICHO SCIENCES trademark is filed in the Pharmaceutical Products category with the following description:

Antibacterial pharmaceuticals; Antivirals; Biometallic compounds being a component in pharmaceutical preparations for infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic reagents for medicinal use; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents; Ocular pharmaceuticals; Pharmaceutical preparations and substances for the treatment of infectious ...
jericho sciences

General Information


Serial Number87783010
Word MarkJERICHO SCIENCES
Filing DateSaturday, February 3, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 27, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 26, 2018

Trademark Statements


Disclaimer with Predetermined Text"SCIENCES"
Goods and ServicesAntibacterial pharmaceuticals; Antivirals; Biometallic compounds being a component in pharmaceutical preparations for infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic reagents for medicinal use; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents; Ocular pharmaceuticals; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Syringes sold filled with pharmaceuticals for treating infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Therapeutic pharmaceutical for the treatment of infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for the prevention and treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 12, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJericho Sciences, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressResearch Triangle, NC 27709

Party NameJericho Sciences, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37203

Trademark Events


Event DateEvent Description
Monday, September 27, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 27, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, February 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 19, 2021EXTENSION 5 GRANTED
Monday, February 15, 2021EXTENSION 5 FILED
Monday, February 15, 2021TEAS EXTENSION RECEIVED
Thursday, August 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 18, 2020EXTENSION 4 GRANTED
Tuesday, August 18, 2020EXTENSION 4 FILED
Tuesday, August 18, 2020TEAS EXTENSION RECEIVED
Friday, February 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 27, 2020EXTENSION 3 GRANTED
Tuesday, February 18, 2020EXTENSION 3 FILED
Thursday, February 27, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 18, 2020TEAS EXTENSION RECEIVED
Thursday, August 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2019EXTENSION 2 GRANTED
Monday, August 19, 2019EXTENSION 2 FILED
Monday, August 19, 2019TEAS EXTENSION RECEIVED
Saturday, February 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 7, 2019EXTENSION 1 GRANTED
Thursday, February 7, 2019EXTENSION 1 FILED
Thursday, February 7, 2019TEAS EXTENSION RECEIVED
Tuesday, August 21, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 26, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 26, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 6, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 17, 2018ASSIGNED TO EXAMINER
Monday, February 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, February 7, 2018NEW APPLICATION ENTERED IN TRAM